Tompkins Financial Corp Novo Cure LTD Transaction History
Tompkins Financial Corp
- $1.17 Billion
- Q3 2025
A detailed history of Tompkins Financial Corp transactions in Novo Cure LTD stock. As of the latest transaction made, Tompkins Financial Corp holds 50 shares of NVCR stock, worth $658. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$658
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
285Shares Held
77.5MCall Options Held
943KPut Options Held
155K-
Black Rock Inc. New York, NY12.1MShares$160 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$142 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.9MShares$90.9 Million9.53% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$84.1 Million0.02% of portfolio
-
State Street Corp Boston, MA2.68MShares$35.3 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.38B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...